Analysis of bipolar maintenance treatment with lithium versus olanzapine utilizing Multi-state Outcome Analysis of Treatments (MOAT)

Bipolar Disorders

Volumn 18, Issue 3, 2016, Pages 282-287

  Tohen, Mauricio ^a   Mintz, Jim ^b   Bowden, Charles L ^b  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b University of Texas Health Science Center at San Antonio   (United States)

Author keywords

Bipolar disorder; Outcome analysis; Treatment

Indexed keywords

LITHIUM SALT; OLANZAPINE; BENZODIAZEPINE DERIVATIVE; LITHIUM DERIVATIVE;

ADULT; ARTICLE; BIPOLAR DISORDER; BOOTSTRAPPING; CHI SQUARE TEST; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; HEALTH STATUS; HUMAN; KAPLAN MEIER METHOD; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MANIA; MONOTHERAPY; MULTI STATE OUTCOME ANALYSIS OF TREATMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; SUBSYNDROMAL DEPRESSION; SUBSYNDROMAL MANIA; SURVIVAL TIME; SYNDROMAL DEPRESSION; SYNDROMAL MANIA; TREATMENT DURATION; TREATMENT OUTCOME; COMPARATIVE STUDY; FEMALE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; BENZODIAZEPINES; BIPOLAR DISORDER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; YOUNG ADULT;

EID: 84963610777     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12383     Document Type: Article

References (14)

1. Bowden CL, Mintz J, Tohen M. Multi-state outcome analysis of treatments (MOAT): application of a new approach to evaluate outcomes in longitudinal studies of bipolar disorder. Mol Psychiatry 2016; 21: 237-242.
2. Goodwin GM, Bowden CL, Calabrese JR et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 2004; 65: 432-441.
3. Tohen M, Greil W, Calabrese JR et al. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. Am J Psychiatry 2005; 162: 1281-1290.
4. Tohen M, Frank E, Bowden CL et al. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 2009; 11: 453-473.
5. Hamilton M. A rating scale for depression. J Neurol Neurosug Psychiatry 1960; 23: 56-62.
6. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
7. 5 D. DSM 5 Fifth ed: American Psychiatry Press.
8. Barker C. The mean, median, and confidence intervals of the kaplan-meier survival estimate-computations and applications. Am Statistician 2009; 63: 78-80.
9. Klein JMM. Survival Analysis-Techniques for Censored and Truncated Data. New York: Springer, 1997.
10. Datta S. Estimating the mean life time using right censored data, 2005.
11. Zhong M, Hess K. Mean survival time from right censored data. Collect Biostat Res Arch 2009; 66: 1-5.
12. Keown-Stoneman CDG, Horrocks J, Darlington GA, Goodday S, Grof P, Duffy A. Multi-state models for investigating possible stages leading to bipolar disorder. Int J Bipolar Disord 2015; 3: 5.
13. Cortese G, Andersen PK. Competing risks and time-dependent covariates. Biom J 2010; 52: 138-158.
14. Coppen A, Peet M, Bailey J et al. Double-blind and open prospective studies of lithium prophylaxis in affective disorders. Psychiatria, Neurologia, Neurochlrurgla 1973; 76: 501-510.